Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphoma.
Sloan SL, Renaldo KA, Long M, Chung JH, Courtney LE, Shilo K, Youssef Y, Schlotter S, Brown F, Klamer BG, Zhang X, Yilmaz AS, Ozer HG, Valli VE, Vaddi K, Scherle P, Alinari L, Kisseberth WC, Baiocchi RA.
Sloan SL, et al.
PLoS One. 2021 May 14;16(5):e0250839. doi: 10.1371/journal.pone.0250839. eCollection 2021.
PLoS One. 2021.
PMID: 33989303
Free PMC article.